|
ZZEF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.9033700000004E-05 |
| Normal-vs-Stage3 |
2.22044604925031E-16 |
| Normal-vs-Stage4 |
1.62625468647093E-12 |
| Stage1-vs-Stage2 |
2.369500E-02 |
| Stage1-vs-Stage3 |
9.923500E-02 |
| Stage1-vs-Stage4 |
9.304300E-03 |
| Stage2-vs-Stage3 |
1.982660E-03 |
| Stage2-vs-Stage4 |
4.600400E-04 |
| Stage3-vs-Stage4 |
3.522800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.03859999992062E-07 |
| Normal-vs-Asian |
2.47309994705347E-09 |
| Caucasian-vs-AfricanAmerican |
8.296800E-01 |
| Caucasian-vs-Asian |
5.493200E-01 |
| AfricanAmerican-vs-Asian |
8.358800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.314000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(41-60Yrs) |
3.5527136788005E-15 |
| Normal-vs-Age(61-80Yrs) |
1.69242397873859E-12 |
| Normal-vs-Age(81-100Yrs) |
2.33749999999366E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.154800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.726800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.505400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.737600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.588000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.055600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.975830E-04 |
| Classical-VS-Follicular |
9.992000E-01 |
| Classical-VS-Other |
7.648100E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.100400E-03 |
| Tall-VS-Other |
7.476800E-01 |
| Tall-VS-Normal |
2.99760216648792E-15 |
| Follicular-VS-Other |
1.286960E-01 |
| Follicular-VS-Normal |
2.90840018735139E-10 |
| Other-VS-Normal |
1.61069999999874E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79856129989275E-14 |
| Normal-vs-N1 |
6.24766904877561E-12 |
| N0-vs-N1 |
1.926390E-01 |
|
|
